In vivo CAR-T engineering: insights from the 2025 ASH annual meeting
{{output}}
In vivo chimeric antigen receptor (CAR)-T engineering is a prominent field of research in cancer immunology, in which vectors are used to reprogram endogenous T-cells into CAR-T cells. Viral and nonviral platforms presented at the 67th Annual Meeting of the Am... ...
